Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pando, B. Prieto, M. Ariza, M. Clemente, C. Madrid, S. Gagatek, H. Buchelli, L. Molinos, P. Casan (Oviedo, Spain). Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term. Eur Respir J 2013; 42: Suppl. 57, 2700

Member's Comments

No comment yet.

Related content which might interest you: Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 The results of immunotherapy of community acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Survival predictors of severe community-acquired pneumonia (CAP): Multivariate analysis of immunological and inflammatory parameters Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Fatal outcomes in patients with community acquired pneumonia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Biomarkers and VAP: results and perspectives Source: Eur Respir Mon 2011; 53: 24-35 Year: 2011 Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Comparison of the prognostic value of different severity scales in community- acquired pneumonia Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Severity scores and management of community acquired pneumonia Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Cytokine and chemokine profile in a cohort of children with community acquired pneumonia Source: International Congress 2016 – Paediatric respiratory infection Year: 2016 The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Performance of early warning score and CURB-65 in predicting severe outcome in community-acquired pneumonia Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Factors affecting treatment success in community acquired pneumonia (CAP) Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013